Healthcare provider profile · identity verified

Edward L. Merker, M.D.

Family Practice · PLEASANTVILLE, NY · NPI 1588653109

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	452	101
Rosuvastatin Calcium	Rosuvastatin Calcium	302	76
Amlodipine Besylate	Amlodipine Besylate	266	64
Losartan Potassium	Losartan Potassium	207	49
Metoprolol Succinate	Metoprolol Succinate	207	49
Furosemide	Furosemide	149	31
Levothyroxine Sodium	Levothyroxine Sodium	144	37
Pantoprazole Sodium	Pantoprazole Sodium	143	29
Tamsulosin Hcl	Tamsulosin Hcl	137	32
Januvia	Sitagliptin Phosphate	134	19
Eliquis	Apixaban	125	26
Lisinopril	Lisinopril	118	32
Omeprazole	Omeprazole	112	23
Allopurinol	Allopurinol	105	26
Metformin Hcl	Metformin Hcl	103	30
Xarelto	Rivaroxaban	90	suppressed
Famotidine	Famotidine	86	19
Zolpidem Tartrate	Zolpidem Tartrate	86	15
Gabapentin	Gabapentin	80	18
Hydrochlorothiazide	Hydrochlorothiazide	80	25
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	78	38
Simvastatin	Simvastatin	76	20
Oseltamivir Phosphate	Oseltamivir Phosphate	71	57
Prednisone	Prednisone	68	22
Escitalopram Oxalate	Escitalopram Oxalate	60	14
Atenolol	Atenolol	58	17
Montelukast Sodium	Montelukast Sodium	57	suppressed
Farxiga	Dapagliflozin Propanediol	54	suppressed
Finasteride	Finasteride	54	11
Carvedilol	Carvedilol	53	15
Duloxetine Hcl	Duloxetine Hcl	51	suppressed
Fluticasone Propionate	Fluticasone Propionate	51	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	51	14
Alprazolam	Alprazolam	49	14
Clonazepam	Clonazepam	41	suppressed
Mirtazapine	Mirtazapine	40	suppressed
Bupropion Xl	Bupropion Hcl	37	suppressed
Irbesartan	Irbesartan	37	suppressed
Jardiance	Empagliflozin	37	suppressed
Potassium Chloride	Potassium Chloride	37	suppressed
Sertraline Hcl	Sertraline Hcl	37	suppressed
Breo Ellipta	Fluticasone/Vilanterol	35	suppressed
Paroxetine Hcl	Paroxetine Hcl	35	11
Mupirocin	Mupirocin	34	17
Carbidopa-Levodopa	Carbidopa/Levodopa	32	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	32	12
Ezetimibe	Ezetimibe	31	suppressed
Glipizide Er	Glipizide	31	suppressed
Levofloxacin	Levofloxacin	30	19
Valsartan	Valsartan	30	suppressed
Clopidogrel	Clopidogrel Bisulfate	29	suppressed
Cefuroxime	Cefuroxime Axetil	27	24
Spironolactone	Spironolactone	26	suppressed
Synthroid	Levothyroxine Sodium	26	suppressed
Chlorthalidone	Chlorthalidone	25	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	25	suppressed
Ketoconazole	Ketoconazole	24	12
Quetiapine Fumarate	Quetiapine Fumarate	24	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	23	suppressed
Glycopyrrolate	Glycopyrrolate	23	suppressed
Ramipril	Ramipril	23	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	22	14
Amiodarone Hcl	Amiodarone Hcl	22	suppressed
Digoxin	Digoxin	22	suppressed
Amoxicillin	Amoxicillin	21	12
Diclofenac Sodium	Diclofenac Sodium	21	suppressed
Latanoprost	Latanoprost	21	suppressed
Tramadol Hcl-Acetaminophen	Tramadol Hcl/Acetaminophen	21	suppressed
Ozempic	Semaglutide	20	suppressed
Trazodone Hcl	Trazodone Hcl	20	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	19	suppressed
Dutasteride	Dutasteride	19	suppressed
Fenofibrate	Fenofibrate	19	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	19	suppressed
Lagevrio (Eua)	Molnupiravir	19	19
Levetiracetam	Levetiracetam	19	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	19	suppressed
Meloxicam	Meloxicam	19	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	18	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	18	suppressed
Albuterol Sulfate	Albuterol Sulfate	17	suppressed
Azelastine Hcl	Azelastine Hcl	17	suppressed
Azithromycin	Azithromycin	17	16
Esomeprazole Magnesium	Esomeprazole Magnesium	17	suppressed
Hydralazine Hcl	Hydralazine Hcl	17	suppressed
Invokana	Canagliflozin	17	suppressed
Telmisartan	Telmisartan	17	suppressed
Budesonide	Budesonide	16	suppressed
Methenamine Hippurate	Methenamine Hippurate	16	suppressed
Pravastatin Sodium	Pravastatin Sodium	16	suppressed
Lactulose	Lactulose	15	suppressed
Olanzapine	Olanzapine	15	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	15	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	14	11
Donepezil Hcl	Donepezil Hcl	14	suppressed
Metformin Hcl Er	Metformin Hcl	14	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	14	14
Tresiba Flextouch U-200	Insulin Degludec	14	suppressed
Ventolin Hfa	Albuterol Sulfate	14	suppressed
Alendronate Sodium	Alendronate Sodium	13	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	13	suppressed
Citalopram Hbr	Citalopram Hydrobromide	13	suppressed
Entresto	Sacubitril/Valsartan	13	suppressed
Metolazone	Metolazone	13	suppressed
Tradjenta	Linagliptin	13	suppressed
Acyclovir	Acyclovir	12	suppressed
Bicalutamide	Bicalutamide	12	suppressed
Enalapril Maleate	Enalapril Maleate	12	suppressed
Haloperidol	Haloperidol	12	suppressed
Lumigan	Bimatoprost	12	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	12	suppressed
Vascepa	Icosapent Ethyl	12	suppressed
Aranesp	Darbepoetin Alfa In Polysorbat	11	suppressed
Bupropion Hcl	Bupropion Hcl	11	suppressed
Carbidopa-Levodopa-Entacapone	Carbidopa/Levodopa/Entacapone	11	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	11	suppressed
Nebivolol Hcl	Nebivolol Hcl	11	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	11	suppressed
Praluent Pen	Alirocumab	11	suppressed
Sodium Chloride	0.9 % Sodium Chloride	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error